Table 1. Overview of guideline recommendations on antithrombotic therapy according to different levels of CHA2DS2-VASc score.
U.S. guideline recommendations† | European guideline recommendations‡ | |||
---|---|---|---|---|
Women | Men | Women | Men | |
CHA2DS2-VASc = 0 | N/A* | No therapy | N/A* | No therapy |
CHA2DS2-VASc = 1 | Oral anticoagulation, aspirin, or no therapy | No therapy | Oral anticoagulation | |
CHA2DS2-VASc ≥2 | Oral anticoagulation | Oral anticoagulation |
*Women cannot score 0, as female sex triggers 1 point in the CHA2DS2-VASc score.
†The American College of Cardiology, the American Heart Associations, and the Heart Rhythm Society (ACC/AHA/HRS). ‡European Society of Cardiology (ESC). N/A: Not available.